SV Investment

Activity in this selectioncompany-k-partners-55c65f7e

By stage

Series A3

Series B2

Biotech2

AI1

Fintech1

Industrial tech1

United States5

5 in this selection

Aug 19

Develops oncolytic immunotherapies for patients with advanced solid tumors

$14MSeries A

Role not disclosed

Jul 2

Builds AI agents for institutional investors to surface market-moving signals in public markets

$22MSeries A

Role not disclosed

Jul 1

Develops deployment-ready robotic intelligence and automation solutions for manufacturing

$40MSeries A

Role not disclosed

May 29

Builds CXL computational memory chips and SDK for AI infrastructure in hyperscalers, telcos, and research

$135MSeries B

Role not disclosed

Feb 25

Develops genetic medicines enabled by precise, non-viral nanoparticle delivery across tissues

$60MSeries B

Role not disclosed